Old Web
English
Sign In
Acemap
>
authorDetail
>
Thais Gomes de Melo
Thais Gomes de Melo
Boehringer Ingelheim
Medicine
Linagliptin
Type 2 diabetes
Glycated hemoglobin
Incretin
6
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Índice de hospitalização e custos associados à doença pulmonar obstrutiva crônica (DPOC) entre estados que padronizaram versus que não padronizaram o tiotrópio – dados do mundo real
2018
Thais Gomes de Melo
Natália Santoni
Beny Finkelstein
Daniela Veiga
Marcos Nascimento
Fábio Rosito
Show All
Source
Cite
Save
Citations (2)
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Perspectives
2015
Value in health regional issues
Camila Pepe Ribeiro de Souza
Natália Santoni
Thais Gomes de Melo
Márcio Jansen de Oliveira Figueiredo
Francisco Carlos da Costa Darrieux
Leopoldo Soares-Piegas
Sheila Ouriques Martins
Show All
Source
Cite
Save
Citations (5)
Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
2013
Diabetology & Metabolic Syndrome
Erika Paniago Guedes
Alexandre Hohl
Thais Gomes de Melo
Felipe Lauand
Show All
Source
Cite
Save
Citations (23)
1